NOMAD Power Solutions, Inc.(NMAD)

Biotechnology · Boca Raton, FL

$4.35+0.33 (+8.22%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

EV/EBIT Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBIT ratio is N/A as of 2026-10-06T21:17:42.853Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:17:42.853Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 53,703,700
Total debt · period ending 2026-06-30: 1,101
Cash · period ending 2026-06-30: 12,670
TTM operating income · period ending 2026-06-30: -7,963,199

FMP input reference: f372f39edc86e990c580289f142e0fc1828f45467bffd466be8591b91f734aee

EV/EBITDA|EV/Sales|Operating Income|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

NMAD EV/EBIT Ratio Metrics

EV/EBIT RATIO

N/A

NMAD Competitors' EV/EBIT Ratio

NMAD

NOMAD Power Solutions, Inc.

Current

Market Cap

$53.70M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RANI

Rani Therapeutics Holdings, Inc.

vs NMAD

Market Cap

$54.14M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDAI

Spectral AI, Inc.

vs NMAD

Market Cap

$52.83M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ZYBT

Zhengye Biotechnology Holding Limited

vs NMAD

Market Cap

$52.60M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALDX

Aldeyra The

vs NMAD

Market Cap

$55.25M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELOX

Eloxx Pharmaceuticals, Inc.

vs NMAD

Market Cap

$51.99M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMA

ImageneBio Inc

vs NMAD

Market Cap

$51.88M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OKYO

OKYO Pharma Limited

vs NMAD

Market Cap

$56.02M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EXOZ

eXoZymes, Inc.

vs NMAD

Market Cap

$51.23M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TENX

Tenax Therapeutics, Inc.

vs NMAD

Market Cap

$51.19M

EV/EBIT Ratio

N/A

TTM Avg

0.77x

3Y Avg

0.98x

5Y Avg

0.98x

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
NOMAD Power Solutions, Inc. (NMAD)	$53.70M	N/A	N/A	N/A	N/A
Rani Therapeutics Holdings, Inc. (RANI)vs ›	$54.14M	N/A	N/A	N/A	N/A
Spectral AI, Inc. (MDAI)vs ›	$52.83M	N/A	N/A	N/A	N/A
Zhengye Biotechnology Holding Limited (ZYBT)vs ›	$52.60M	N/A	N/A	N/A	N/A
Aldeyra The (ALDX)vs ›	$55.25M	N/A	N/A	N/A	N/A
Eloxx Pharmaceuticals, Inc. (ELOX)vs ›	$51.99M	N/A	N/A	N/A	N/A
ImageneBio Inc (IMA)vs ›	$51.88M	N/A	N/A	N/A	N/A
OKYO Pharma Limited (OKYO)vs ›	$56.02M	N/A	N/A	N/A	N/A
eXoZymes, Inc. (EXOZ)vs ›	$51.23M	N/A	N/A	N/A	N/A
Tenax Therapeutics, Inc. (TENX)vs ›	$51.19M	N/A	0.77x	0.98x	0.98x

EV/EBIT Ratio Formula & Definition

EV/EBIT = Enterprise Value / EBIT (TTM)

Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBIT Ratio: N/A

NMAD EV/EBIT Ratio Metrics

NMAD Competitors' EV/EBIT Ratio

EV/EBIT Ratio Formula & Definition

Related Metrics